Cite
HARVARD Citation
Gomez, F. et al. (n.d.). FRI0197 EFFICACY DATA OF MC2–03 (CICLOSPORIN 0.03% AND 0.06% EYEDROPS) IN SJOGREN'S PATIENTS WITH SEVERE KERATITIS: OUTCOMES OF THE NORTHERN LIGHTS PHASE 2B TRIAL. Annals of the rheumatic diseases. p. 777. [Online].